VLP Therapeutics raises $21M Series A-1 for cancer treatment vaccine, infectious diseases vaccine R&D

/PRNewswire/ -- US-based biotech company VLP Therapeutics, Inc. (VLPT) announced on December 27 that it has signed an agreement for an investment of US$21...

Related Keywords

Japan ,Tokyo ,Kyoto ,Yutaka Iijima ,Hayami Masanori ,Sachiko Kuno ,Wataru Akahata ,Ryuji Ueno ,Vaccine Research Center ,Global Communications ,National Institutes Of Health ,Tokyo Institute Of Technology ,Kyoto University Graduate School Of Medicine ,Therapeutics Japan ,Therapeutics Inc ,Kyoto University Institute For Virus Research ,University Of Tokyo ,Kyoto University Graduate School Of Human ,Kyoto University ,Graduate School ,Kyoto University Institute ,National Institutes ,Nature Medicine ,Tokyo Institute ,Kyoto University Graduate School ,Vlp Therapeutics ,Nc ,